CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors

PURPOSE: Pancreatic cancer is associated with a high mortality rate owing to insufficient approaches for early diagnosis and the invasive biological behavior of the cancer. CD26 is a membrane-anchored protein involved in multiple physiological and pathological processes. Here, we investigated correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Liang, Tian, Xiuyun, Ye, Chunxiang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Hao, Chunyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737554/
https://www.ncbi.nlm.nih.gov/pubmed/33335402
http://dx.doi.org/10.2147/OTT.S278736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737554/
https://www.ncbi.nlm.nih.gov/pubmed/33335402
http://dx.doi.org/10.2147/OTT.S278736

Ejemplares similares